Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-11 · accession 0001601830-25-000130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | +423.7K | 1.50M | +39% | $0 |
| D | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | S - Sale | $5.28 | -500.3K | 1.00M | -33% | -$2.64M |
| D | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | G - Gift | $0.00 | -10.0K | 994.6K | -1.0% | $0 |
| DMI | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | S - Sale | $5.28 | -117.9K | 0 | -100% | -$622.4K |
| DMI | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | +117.9K | 17.9K | New | $0 |
| DMI | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | -117.9K | 386.0K | -23% | $0 |
| D | 2025-08-13 | 2025-08-11 | RXRX | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | -423.7K | 5.47M | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-08-11 | C | A | 423,666 | $0.00 | 1,504,919 | D by LAHWRAN-3 LLC | — | — | (F4) The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. |
| 2 | Common | Class A Common Stock | 2025-08-11 | S | D | 500,300 | $5.28 | 1,004,619 | D by LAHWRAN-3 LLC | — | — | (F4) The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. |
| 3 | Common | Class A Common Stock | 2025-08-11 | G | D | 10,000 | $0.00 | 994,619 | D by Gibson Family Trust | — | — | (F5) The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. |
| 4 | Common | Class A Common Stock | 2025-08-11 | S | D | 17,875 | $5.28 | 0 | I | — | — | |
| 5 | Common | Class A Common Stock | 2025-08-11 | C | A | 100,000 | $0.00 | 100,000 | I by Gibson Family Trust | — | — | (F5) The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. |
| 6 | Common | Class A Common Stock | 2025-08-11 | S | D | 100,000 | $5.28 | 0 | I | — | — | |
| 7 | Common | Class A Common Stock | 2025-08-11 | C | A | 17,875 | $0.00 | 17,875 | I | — | — | |
| 8 | Derivative | Class B Common Stock | 2025-08-11 | C | D | 17,875 | $0.00 | 50,000 | I | $0.00 · — to — | 17,875 Class A Common Stock | (F6) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. |
| 9 | Derivative | Class B Common Stock | 2025-08-11 | C | D | 100,000 | $0.00 | 386,000 | I by Gibson Family Trust | $0.00 · — to — | 100,000 Class A Common Stock | (F5) The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. (F6) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. |
| 10 | Derivative | Class B Common Stock | 2025-08-11 | C | D | 423,666 | $0.00 | 5,473,034 | D by LAHWRAN-3 LLC | $0.00 · — to — | 423,666 Class A Common Stock | (F4) The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. (F6) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. |